Pharmaceutical Technology22 小时
Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...
Pharmaceutical Technology22 小时
Tevimbra by BeiGene for Muscle Invasive Bladder Cancer (MIBC): Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Muscle Invasive Bladder Cancer (MIBC).
Everyday Health10 小时
Our Top Celebrity Health Stories of 2024
Kate Middleton’s cancer diagnosis was big health news in 2024, with other famous names like Lance Bass and Wendy Williams ...
The New Republic on MSN8 小时Opinion
74-Year-Old Democrat Who Ran Against AOC Offers Infuriating Defense
Representative Gerry Connolly beat Alexandria Ocasio-Cortez in a race for a top leadership spot in the party—and then ...